Intelligent organizations prioritize investments in machine learning and real-time data to improve decision making, accelerate revenue generation efforts, reduce operational expenses and protect ...

Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...